Covalis Capital’s Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant ACII.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-50,000
Closed -$501K 179
2021
Q1
$501K Buy
+50,000
New +$523K 0.1% 68

Other funds holding ACII.U

Covalis Capital's ACII.U Position: Q2 2021 in Review

Covalis Capital sold out of Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant (ACII.U) in Q2 2021, closing a stake of 50,000 shares — an estimated $501K sold.

Covalis Capital first reported a position in ACII.U in Q1 2021 and held it in 1 quarter. The position peaked at $501K in Q1 2021. 53 funds tracked by Wall St. Rank hold ACII.U as of Q2 2021.

  • Covalis Capital reported no remaining Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
  • Covalis Capital sold 50,000 Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant shares in Q2 2021, an estimated $501K.
  • Covalis Capital first reported a position in Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant in Q1 2021 and held it in 1 quarter.
  • Covalis Capital's Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant position peaked at $501K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant as of Q2 2021.

Based on Covalis Capital's 13F filing for Q2 2021, filed 16 Aug 2021.